Dr Yvonne Greenstreet has joined Pfizer to head up medicines development for its Specialty Care business unit. She moves to …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

